184 related articles for article (PubMed ID: 16361740)
1. A case of photocontact urticaria induced by photodynamic therapy with topical 5-aminolaevulinic acid.
Yokoyama S; Nakano H; Nishizawa A; Kaneko T; Harada K; Hanada K
J Dermatol; 2005 Oct; 32(10):843-7. PubMed ID: 16361740
[TBL] [Abstract][Full Text] [Related]
2. Acute phototoxicity with urticarial features during topical 5-aminolaevulinic acid photodynamic therapy.
Kerr AC; Ferguson J; Ibbotson SH
Clin Exp Dermatol; 2007 Mar; 32(2):201-2. PubMed ID: 17244343
[No Abstract] [Full Text] [Related]
3. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
4. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
Ibbotson SH; Valentine R; Hearn R
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
6. Remission of a cutaneous Mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection.
Paech V; Lorenzen T; Stoehr A; Lange K; Merz H; Meigel WN; Plettenberg A
Eur J Med Res; 2002 Nov; 7(11):477-9. PubMed ID: 12568975
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 and nitric oxide mediate the acute inflammatory (erythemal) response to topical 5-aminolaevulinic acid photodynamic therapy in human skin.
Brooke RC; Sidhu M; Sinha A; Watson RE; Friedmann PS; Clough GF; Rhodes LE
Br J Dermatol; 2013 Sep; 169(3):645-52. PubMed ID: 23909846
[TBL] [Abstract][Full Text] [Related]
9. The characteristics of erythema induced by topical 5-aminolaevulinic acid photodynamic therapy.
Clark C; Dawe RS; Moseley H; Ferguson J; Ibbotson SH
Photodermatol Photoimmunol Photomed; 2004 Apr; 20(2):105-7. PubMed ID: 15030596
[TBL] [Abstract][Full Text] [Related]
10. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P
Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612
[TBL] [Abstract][Full Text] [Related]
11. Observation of clinical efficacy of photodynamic therapy in 3 patients with refractory plaque-stage mycosis fungoides.
Han D; Xue J; Wang T; Liu Y
Photodiagnosis Photodyn Ther; 2016 Dec; 16():9-11. PubMed ID: 27503781
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides.
Kim ST; Kang DY; Kang JS; Baek JW; Jeon YS; Suh KS
Acta Derm Venereol; 2012 May; 92(3):264-8. PubMed ID: 22170261
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
Cosgarea R; Susan M; Crisan M; Senila S
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
[TBL] [Abstract][Full Text] [Related]
14. Mycosis fungoides showing incomplete response to topical 5-aminolaevulinic acid phototherapy.
Kim EH; Kang HY; Lee ES; Kim YC
Eur J Dermatol; 2007; 17(4):343-5. PubMed ID: 17540651
[No Abstract] [Full Text] [Related]
15. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
Lang K; Schulte KW; Ruzicka T; Fritsch C
Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
[TBL] [Abstract][Full Text] [Related]
16. Disappointing results and low tolerability of photodynamic therapy with topical 5-aminolaevulinic acid in psoriasis. A randomized, double-blind phase I/II study.
Schleyer V; Radakovic-Fijan S; Karrer S; Zwingers T; Tanew A; Landthaler M; Szeimies RM
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):823-8. PubMed ID: 16898905
[TBL] [Abstract][Full Text] [Related]
17. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
Wolfe CM; Green WH; Hatfield HK; Cognetta AB
J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
[TBL] [Abstract][Full Text] [Related]
18. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
Wiegell SR; Stender IM; Na R; Wulf HC
Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
Schacht V; Szeimies RM; Abels C
Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
[TBL] [Abstract][Full Text] [Related]
20. Topical aminolevulinic acid HCl photodynamic therapy.
Ormrod D; Jarvis B
Am J Clin Dermatol; 2000; 1(2):133-9; discussion 140-1. PubMed ID: 11702313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
